Sfoglia per Autore
Efficacy and clinical outcome of Philadelphia positive Acute Lymphoblastic Leukemia patients treated with second generation tyrosine kinase inhibitors (TKIS): the Bologna experience
2009 Papayannidis C; Iacobucci I; Soverini S; Colarossi S; Gnani A; Lonetti A; Testoni N; Amabile M; Ottaviani E; Abbenante M; Curti A; Paolini S; Lama B; Castagnetti F.; Poerio A; Clissa C; Parisi S; Guadagnuolo V; Piccaluga PP; Rosti G; Baccarani M; Martinelli G
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience
2009 Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandra; Lonetti, Annalisa; Baldazzi, Carmen; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Maria Chiara Abbenante, ; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Castagnetti, Fausto; Poerio, Angela; Clissa, Cristina; Parisi, Sarah; Polverelli, Nicola; Guadagnuolo, Viviana; Pier Paolo Piccaluga, ; Rosti, Gianantonio; Baccarani, Michele; Martinelli, Giovanni
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification?
2009 PP Piccaluga; F Bacci; E Sabattini; M Rossi; A Gazzola; MR Sapienza; C Mannu; S Righi; C Bertuzzi; C Agostinelli; MT Sista; C Laterza; S Parisi; SA Pileri
Efficacy and Feasibility of Nelarabine Savage Therapy In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) Strongly Indicates the Introduction of a Nelarabine-Based First Line Regimen
2010 Cristina Papayannidis, Ilaria Iacobucci, Mariachiara Abbenante, Stefania Paolini, Sarah Parisi, Annalisa Lonetti, Viviana Guadagnuolo, Anna Ferrari, Emanuela Ottaviani, Nicoletta Testoni, Antonio Curti, Cristina Clissa, Michele Baccarani, Giovanni Martinelli
Efficacy and Feasibility of Nelarabine Savage Therapy In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) Strongly Indicates the Introduction of a Nelarabine-Based First Line Regimen
2010 C Papayannidis; I Iacobucci; M Abbenante; S Paolini; S Parisi; A Lonetti; V Guadagnuolo; A Ferrari; E Ottaviani; N Testoni; A Curti; C Clissa; M Baccarani; G Martinelli
Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience
2010 Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandra; Lonetti, Annalisa; Ferrari, Anna; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Maria Chiara Abbenante, ; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Clissa, Cristina; Parisi, Sarah; Guadagnuolo, Viviana; Baccarani, Michele; Martinelli, Giovanni
FROM DIAGNOSIS TO RELAPSE: AN HIGH-RESOLUTION MOLECULAR ALLELOKARYOTYPING ANALYSIS OF PAIRED DIAGNOSIS-RELAPSE SAMPLES IN BCR-ABL1-POSITIVE ALL INDICATES INVOLVEMENT OF ALTERATIONS TARGETING KEY REGULATORS OF TUMOR SUPPRESSION, CELL CYCLE CONTROL, AND LYMPHOID/B CELL DEVELOPMENT
2010 Iacobucci I; Lonetti A; Ferrari A; Papayannidis C; Abbenante M; Ottaviani E; Paolini S; Guadagnuolo V; Parisi S; Vitale A; Vignetti M; Cilloni D; Pane F; Soverini S; Foà R; Baccarani M; Martinelli G
EFFICACY AND FEASIBILITY OF NELARABINE SAVAGE THERAPY IN ADULT RELAPSED OR REFRACTORY T CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) OR LYMPHOBLASTIC LYMPHOMA (T-LBL): A SINGLE-CENTER EXPERIENCE
2010 C Papayannidis ;I Iacobucci ;M C Abbenante ;S Paolini ;S Parisi ;A Lonetti ;V Guadagnuolo ;A Ferrari ;E Ottaviani ;N Testoni ;A Curti ;C Clissa ;M Baccarani ;G Martinelli
LOSS OF THE TUMOR SUPPRESSOR GENE CDKN2A/ARF BY GENOMIC DELETIONS IS A FREQUENT EVENT IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS AND CONTRIBUTES TO DISEASE PROGRESSION
2010 I Iacobucci ;A Ferrari ;A Lonetti ;C Papayannidis ;V Guadaguolo ;C Storlazzi ;E Ottaviani ; M Abbenante ;S Paolini ;S Parisi ;D Cilloni ;S Soverini ;F Pane ;A Vitale ;B Lama ;R Foà ;M Baccarani ;G Martinelli
The Inactivation of the Tumor Suppressor Genes CDKN2A/ARF by Genomic Deletions Frequently Occurs and Worsens Prognosis In Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Patients
2010 Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Guadagnuolo V; Ottavini E; Abbenante M; Cattina F; Vitale A; Paolini S; Soverini S; Parisi S; Paoloni F; Castagnetti F; Vignetti M; Foà R; Baccarani M; Martinelli G.
Use of a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript In Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL).
2010 I. Iacobucci; A. Lonetti; A. Ferrari; C. Papayannidis; S. Soverini; S. Paolini; M. Abbenante; V. Guadagnuolo; S. Parisi; L. Potenza; M. Luppi; F. Cattina; D. Russo; F. Pane; M. Baccarani; G. Martinelli
Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients
2010 I. Iacobucci; A. Lonetti; A. Candoni; M. Sazzini; S. Formica; E. Ottaviani; A. Ferrari; C. Papayannidis; A. Michelutti; E. Toffoletti; A. Astolfi; S. Paolini; M. Abbenante; S. Parisi; D. Russo; D. Damiani; F. Gherlinzoni; M. Gottardi; M. Baccarani; R. Fanin; G. Martinelli
Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patient with breast infiltration
2010 Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Parisi S; Paolini S; Testoni N; Baccarani M; Cilloni D; Martinelli G
Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient.
2010 Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Paolini S; Parisi S; Baccarani M; Martinelli G.
LOSS OF THE TUMOR SUPPRESSOR GENE CDKN2A/ARF IS FREQUENTLY DELETED BUT NOT MUTATED IN BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
2010 Ferrari A; Iacobucci I; Lonetti A; Papayannidis C; Paolini S; Parisi S; Abbenante M; Guadagnuolo V; Soverini S; Cilloni D; Pane F; Baccarani M; Martinelli G
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response
2011 C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani
Pediatric-Like Intensified Therapy In Adult Acute Lymphoblastic Leukemia: A Single Centre Experience
2011 Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, Cristina Papayannidis, Mariachiara Abbenante, Antonio Curti, Emanuela Ottaviani, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli
PHARMACOGENOMIC PROFILE ASSOCIATED WITH HIGH SENSITIVITY AND LOW TOXICITY TO A COMBINATION OF GEMTUZUMAB OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN IN CD33-POSITIVE ACUTE MYELOID LEUKEMIA
2011 I Iacobucci ;A Lonetti ;A Candoni ;M Sazzini ;S Formica ;E Ottaviani ;A Ferrari ;C Papayannidis ;A Michelutti ;E Toffoletti ;A Astolfi ;S Paolini ;MC Abbenante ;S Parisi ;F Cattina ;D Russo ;D Damiani ;F Gherlinzoni ;E Gottardi ;M Baccarani ;R Fanin ;G Martinelli
FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE (FLAIE) SCHEDULE IS SAFE AND ACTIVE FOR YOUNG PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF A MULTICENTRIC PHASE III ITALIAN STUDY
2011 C Papayannidis ;I Iacobucci ;A Candoni ;MC Abbenante ;S Paolini ;M Malagola ;E Ottaviani ;A Lonetti ;A Curti ;S Parisi ;N Testoni ;B Lama ;M Baccarani ;G Martinelli
Fludarabine, Cytarabine, Idarubicin and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed acute myeloid leukemia (AML): Results of a multicentric phase III Italian study
2011 Mariachiara Abbenante, Cristina Papayannidis, Ilaria Iacobucci, Anna Candoni, Stefania Paolini, Michele Malagola, Ottaviani Emanuela, Annalisa Lonetti, Antonio Curti, Sarah Parisi, Nicoletta Testoni, Barbara Lama, Michele Baccarani, Giovanni Martinelli
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Efficacy and clinical outcome of Philadelphia positive Acute Lymphoblastic Leukemia patients treated with second generation tyrosine kinase inhibitors (TKIS): the Bologna experience | Papayannidis C; Iacobucci I; Soverini S; Colarossi S; Gnani A; Lonetti A; Testoni N; Amabile M; O...ttaviani E; Abbenante M; Curti A; Paolini S; Lama B; Castagnetti F.; Poerio A; Clissa C; Parisi S; Guadagnuolo V; Piccaluga PP; Rosti G; Baccarani M; Martinelli G | 2009-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience | Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandr...a; Lonetti, Annalisa; Baldazzi, Carmen; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Maria Chiara Abbenante, ; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Castagnetti, Fausto; Poerio, Angela; Clissa, Cristina; Parisi, Sarah; Polverelli, Nicola; Guadagnuolo, Viviana; Pier Paolo Piccaluga, ; Rosti, Gianantonio; Baccarani, Michele; Martinelli, Giovanni | 2009-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? | PP Piccaluga; F Bacci; E Sabattini; M Rossi; A Gazzola; MR Sapienza; C Mannu; S Righi; C Bertuzzi...; C Agostinelli; MT Sista; C Laterza; S Parisi; SA Pileri | 2009-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |
| Efficacy and Feasibility of Nelarabine Savage Therapy In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) Strongly Indicates the Introduction of a Nelarabine-Based First Line Regimen | Cristina Papayannidis, Ilaria Iacobucci, Mariachiara Abbenante, Stefania Paolini, Sarah Parisi, A...nnalisa Lonetti, Viviana Guadagnuolo, Anna Ferrari, Emanuela Ottaviani, Nicoletta Testoni, Antonio Curti, Cristina Clissa, Michele Baccarani, Giovanni Martinelli | 2010-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| Efficacy and Feasibility of Nelarabine Savage Therapy In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL) Strongly Indicates the Introduction of a Nelarabine-Based First Line Regimen | C Papayannidis; I Iacobucci; M Abbenante; S Paolini; S Parisi; A Lonetti; V Guadagnuolo; A Ferrar...i; E Ottaviani; N Testoni; A Curti; C Clissa; M Baccarani; G Martinelli | 2010-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience | Papayannidis, Cristina; Iacobucci, Ilaria; Soverini, Simona; Colarossi, Sabrina; Gnani, Alessandr...a; Lonetti, Annalisa; Ferrari, Anna; Testoni, Nicoletta; Amabile, Marilina; Ottaviani, Emanuela; Maria Chiara Abbenante, ; Curti, Antonio; Paolini, Stefania; Lama, Barbara; Clissa, Cristina; Parisi, Sarah; Guadagnuolo, Viviana; Baccarani, Michele; Martinelli, Giovanni | 2010-01-01 | CANCER RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| FROM DIAGNOSIS TO RELAPSE: AN HIGH-RESOLUTION MOLECULAR ALLELOKARYOTYPING ANALYSIS OF PAIRED DIAGNOSIS-RELAPSE SAMPLES IN BCR-ABL1-POSITIVE ALL INDICATES INVOLVEMENT OF ALTERATIONS TARGETING KEY REGULATORS OF TUMOR SUPPRESSION, CELL CYCLE CONTROL, AND LYMPHOID/B CELL DEVELOPMENT | Iacobucci I; Lonetti A; Ferrari A; Papayannidis C; Abbenante M; Ottaviani E; Paolini S; Guadagnuo...lo V; Parisi S; Vitale A; Vignetti M; Cilloni D; Pane F; Soverini S; Foà R; Baccarani M; Martinelli G | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| EFFICACY AND FEASIBILITY OF NELARABINE SAVAGE THERAPY IN ADULT RELAPSED OR REFRACTORY T CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) OR LYMPHOBLASTIC LYMPHOMA (T-LBL): A SINGLE-CENTER EXPERIENCE | C Papayannidis ;I Iacobucci ;M C Abbenante ;S Paolini ;S Parisi ;A Lonetti ;V Guadagnuolo ;A Ferr...ari ;E Ottaviani ;N Testoni ;A Curti ;C Clissa ;M Baccarani ;G Martinelli | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| LOSS OF THE TUMOR SUPPRESSOR GENE CDKN2A/ARF BY GENOMIC DELETIONS IS A FREQUENT EVENT IN ADULT BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS AND CONTRIBUTES TO DISEASE PROGRESSION | I Iacobucci ;A Ferrari ;A Lonetti ;C Papayannidis ;V Guadaguolo ;C Storlazzi ;E Ottaviani ; M Abb...enante ;S Paolini ;S Parisi ;D Cilloni ;S Soverini ;F Pane ;A Vitale ;B Lama ;R Foà ;M Baccarani ;G Martinelli | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| The Inactivation of the Tumor Suppressor Genes CDKN2A/ARF by Genomic Deletions Frequently Occurs and Worsens Prognosis In Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL) Patients | Iacobucci I; Ferrari A; Lonetti A; Papayannidis C; Guadagnuolo V; Ottavini E; Abbenante M; Cattin...a F; Vitale A; Paolini S; Soverini S; Parisi S; Paoloni F; Castagnetti F; Vignetti M; Foà R; Baccarani M; Martinelli G. | 2010-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Use of a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript In Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL). | I. Iacobucci; A. Lonetti; A. Ferrari; C. Papayannidis; S. Soverini; S. Paolini; M. Abbenante; V. ...Guadagnuolo; S. Parisi; L. Potenza; M. Luppi; F. Cattina; D. Russo; F. Pane; M. Baccarani; G. Martinelli | 2010-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Identification of A Pharmacogenomic Profile Associated with High Sensitivity and Low Toxicity to a Combination of Gemtuzumab Ozogamicin Plus Fludarabine, Cytarabine, Idarubicin Regimen In CD33-Positive Acute Myeloid Leukemia (AML) Patients | I. Iacobucci; A. Lonetti; A. Candoni; M. Sazzini; S. Formica; E. Ottaviani; A. Ferrari; C. Papaya...nnidis; A. Michelutti; E. Toffoletti; A. Astolfi; S. Paolini; M. Abbenante; S. Parisi; D. Russo; D. Damiani; F. Gherlinzoni; M. Gottardi; M. Baccarani; R. Fanin; G. Martinelli | 2010-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) patient with breast infiltration | Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Parisi S; Paolini S; Testoni N; Baccarani M; ...Cilloni D; Martinelli G | 2010-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient. | Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Paolini S; Parisi S; Baccarani M; Martinelli G. | 2010-01-01 | AMERICAN JOURNAL OF HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| LOSS OF THE TUMOR SUPPRESSOR GENE CDKN2A/ARF IS FREQUENTLY DELETED BUT NOT MUTATED IN BCR-ABL1-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS | Ferrari A; Iacobucci I; Lonetti A; Papayannidis C; Paolini S; Parisi S; Abbenante M; Guadagnuolo ...V; Soverini S; Cilloni D; Pane F; Baccarani M; Martinelli G | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response | C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; ...L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.02 Riassunto (Abstract) | - |
| Pediatric-Like Intensified Therapy In Adult Acute Lymphoblastic Leukemia: A Single Centre Experience | Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, Cristina Papayannidis, Mariachiara Abbenante, A...ntonio Curti, Emanuela Ottaviani, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli | 2011-01-01 | BLOOD | - | 1.06 Abstract in rivista | - |
| PHARMACOGENOMIC PROFILE ASSOCIATED WITH HIGH SENSITIVITY AND LOW TOXICITY TO A COMBINATION OF GEMTUZUMAB OZOGAMICIN PLUS FLUDARABINE, CYTARABINE, IDARUBICIN IN CD33-POSITIVE ACUTE MYELOID LEUKEMIA | I Iacobucci ;A Lonetti ;A Candoni ;M Sazzini ;S Formica ;E Ottaviani ;A Ferrari ;C Papayannidis ;...A Michelutti ;E Toffoletti ;A Astolfi ;S Paolini ;MC Abbenante ;S Parisi ;F Cattina ;D Russo ;D Damiani ;F Gherlinzoni ;E Gottardi ;M Baccarani ;R Fanin ;G Martinelli | 2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| FLUDARABINE, CYTARABINE, IDARUBICIN AND ETOPOSIDE (FLAIE) SCHEDULE IS SAFE AND ACTIVE FOR YOUNG PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: RESULTS OF A MULTICENTRIC PHASE III ITALIAN STUDY | C Papayannidis ;I Iacobucci ;A Candoni ;MC Abbenante ;S Paolini ;M Malagola ;E Ottaviani ;A Lonet...ti ;A Curti ;S Parisi ;N Testoni ;B Lama ;M Baccarani ;G Martinelli | 2011-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Fludarabine, Cytarabine, Idarubicin and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed acute myeloid leukemia (AML): Results of a multicentric phase III Italian study | Mariachiara Abbenante, Cristina Papayannidis, Ilaria Iacobucci, Anna Candoni, Stefania Paolini, M...ichele Malagola, Ottaviani Emanuela, Annalisa Lonetti, Antonio Curti, Sarah Parisi, Nicoletta Testoni, Barbara Lama, Michele Baccarani, Giovanni Martinelli | 2011-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile